1[1]Gearing KL, Crickmore A, Gustafsson JA. Structure of the mouse peroxisome proliferator activated receptor α gene. Biochem Biophys Res, 1994, 199: 255-263
2[2]Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARs) and their effect on lipid metabolism and adipocyte differentiation. Biochem Biophys Acta, 1996, 1 302: 93-97
3[3]Upenberg A, Jeannin E, Wahi W, et al. Polarity and specific sequence requirerments of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. J Biol Chem, 1997, 272: 20 108-111
4[4]Delerive P, Bosscher KD, Besnard S, et al. Peroxisome proliferator-activated receptorαnegatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J Biol Chem, 1999, 274: 32 048
6[6]Max N, Sukhova GK, Collins T, et al. PPAR alpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation, 1999, 99: 3 125-131
7[7]Neve BP, Corseaux D, Chinetti G, et al. PPAR α agonists inhibit tissue factor expression in human monocytes and macrophages. Circulation, 2001, 103: 207-212
8[8]Staels B, Koening W, Habib A, et al. Activation of human aortic smooth muscle cell is inhibited by PPAR α but not by PPAR γ activators. Nature, 1998, 393: 790
9[9]Madej A, Okopien B, Kowalski J, et al. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia Ⅱb. Int J Pharmacol Thera, 1998, 36: 345-349
10[10]Delerive P, Gervois P, Fruchart JC, et al. Induction of IκBαexpression as a mechanism contributing to the anti-inflammatory activities of PPAR α activators. J Biol Chem, 2000, 275: 36 703-707
2Messi MC, Juhan VI. Contribution of PAI 1 in cardiovascular pathology[J] .Arch Mal Coeur Vaiss,2004,97:673-678.
3Barbler O, Torra I, Pineda P. Actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis[J]. American Heart Association Inc, 2002,22 : 717-726.
4Eriksson P, Nilsson L, Karpe F, et al. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhititor-1 gene implicatcd in the impaired fibrinolysis of hypertriglyceridemia[J]. Arterioscler Thromb Verse Biol, 1998, 18 : 20-26.
5Neurmann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction[ J ]. Circulation,1995,92 : 748-755.
6Archana M, Ashok C, Sanjeev S. Oxidized omega-3 fatty acids inhibit NF-kB activation via a PPARα-dependent pathway [ J ]. Arterioscler Thromb Vase Biol,2004,24: 1621-1627.
